SB505124 HCl
featured

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H527769

CAS#: 356559-13-2 (HCl)

Description: SB05124 HCl is an inhibitor of activin receptor-like kinase (ALK) 5.


Chemical Structure

img
SB505124 HCl
CAS# 356559-13-2 (HCl)

Theoretical Analysis

Hodoodo Cat#: H527769
Name: SB505124 HCl
CAS#: 356559-13-2 (HCl)
Chemical Formula: C20H22ClN3O2
Exact Mass: 0.00
Molecular Weight: 371.870
Elemental Analysis: C, 64.60; H, 5.96; Cl, 9.53; N, 11.30; O, 8.60

Price and Availability

Size Price Availability Quantity
5mg USD 315
10mg USD 550 2 Weeks
25mg USD 1150
Bulk inquiry

Related CAS #: 356559-13-2 (HCl)   694433-59-5 (free base)  

Synonym: SB505124 HCl; SB 505124 HCl; SB-505124 HCl

IUPAC/Chemical Name: 2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride

InChi Key: BTUOOXPZOVNPMF-UHFFFAOYSA-N

InChi Code: InChI=1S/C20H21N3O2.ClH/c1-12-6-5-7-14(21-12)18-17(22-19(23-18)20(2,3)4)13-8-9-15-16(10-13)25-11-24-15;/h5-10H,11H2,1-4H3,(H,22,23);1H

SMILES Code: CC1=CC=CC(C2=C(C3=CC=C(OCO4)C4=C3)N=C(C(C)(C)C)N2)=N1.[H]Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 371.87 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Go YY, Kim SE, Cho GJ, Chae SW, Song JJ. Differential effects of amnion and chorion membrane extracts on osteoblast-like cells due to the different growth factor composition of the extracts. PLoS One. 2017 Aug 10;12(8):e0182716. doi: 10.1371/journal.pone.0182716. eCollection 2017. PubMed PMID: 28797129; PubMed Central PMCID: PMC5552222.

2: Zhang H, Du L, Zhong Y, Flanders KC, Roberts JD Jr. Transforming growth factor-β stimulates Smad1/5 signaling in pulmonary artery smooth muscle cells and fibroblasts of the newborn mouse through ALK1. Am J Physiol Lung Cell Mol Physiol. 2017 Sep 1;313(3):L615-L627. doi: 10.1152/ajplung.00079.2017. Epub 2017 Jun 22. PubMed PMID: 28642261; PubMed Central PMCID: PMC5625261.

3: Kim BH, Guardia Clausi M, Frondelli M, Nnah IC, Saqcena C, Dobrowolski R, Levison SW. Age-Dependent Effects of ALK5 Inhibition and Mechanism of Neuroprotection in Neonatal Hypoxic-Ischemic Brain Injury. Dev Neurosci. 2017;39(1-4):338-351. doi: 10.1159/000477490. Epub 2017 Jun 20. PubMed PMID: 28628913; PubMed Central PMCID: PMC5555313.

4: van Caam A, Madej W, Garcia de Vinuesa A, Goumans MJ, Ten Dijke P, Blaney Davidson E, van der Kraan P. TGFβ1-induced SMAD2/3 and SMAD1/5 phosphorylation are both ALK5-kinase-dependent in primary chondrocytes and mediated by TAK1 kinase activity. Arthritis Res Ther. 2017 May 31;19(1):112. doi: 10.1186/s13075-017-1302-4. PubMed PMID: 28569204; PubMed Central PMCID: PMC5452635.

5: Jiang J, Zhang Y, Peng K, Wang Q, Hong X, Li H, Fan G, Zhang Z, Gong T, Sun X. Combined delivery of a TGF-β inhibitor and an adenoviral vector expressing interleukin-12 potentiates cancer immunotherapy. Acta Biomater. 2017 Oct 1;61:114-123. doi: 10.1016/j.actbio.2017.05.009. Epub 2017 May 5. PubMed PMID: 28483693.

6: Wang J, Chen Y, Gu D, Zhang G, Chen J, Zhao J, Wu P. Ketamine-induced bladder fibrosis involves epithelial-to-mesenchymal transition mediated by transforming growth factor-β1. Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F961-F972. doi: 10.1152/ajprenal.00686.2016. Epub 2017 Mar 22. PubMed PMID: 28331066.

7: Chang HM, Fang Y, Liu PP, Cheng JC, Yang X, Leung PC. Connective tissue growth factor mediates growth differentiation factor 8-induced increase of lysyl oxidase activity in human granulosa-lutein cells. Mol Cell Endocrinol. 2016 Oct 15;434:186-98. doi: 10.1016/j.mce.2016.07.007. Epub 2016 Jul 5. PubMed PMID: 27392496.

8: Terakawa J, Rocchi A, Serna VA, Bottinger EP, Graff JM, Kurita T. FGFR2IIIb-MAPK Activity Is Required for Epithelial Cell Fate Decision in the Lower Müllerian Duct. Mol Endocrinol. 2016 Jul;30(7):783-95. doi: 10.1210/me.2016-1027. Epub 2016 May 10. PubMed PMID: 27164167; PubMed Central PMCID: PMC4926232.

9: Rateitschak K, Kaderali L, Wolkenhauer O, Jaster R. Autocrine TGF-β/ZEB/microRNA-200 signal transduction drives epithelial-mesenchymal transition: Kinetic models predict minimal drug dose to inhibit metastasis. Cell Signal. 2016 Aug;28(8):861-70. doi: 10.1016/j.cellsig.2016.03.002. Epub 2016 Mar 19. PubMed PMID: 27000495.

10: Guardia Clausi M, Levison SW. Delayed ALK5 inhibition improves functional recovery in neonatal brain injury. J Cereb Blood Flow Metab. 2017 Mar;37(3):787-800. doi: 10.1177/0271678X16638669. Epub 2016 Jul 20. PubMed PMID: 26984936; PubMed Central PMCID: PMC5363459.

11: Kim H, Kei K, Sonn JK. Staurosporine induces chondrogenesis of chick embryo wing bud mesenchyme in monolayer cultures through canonical and non-canonical TGF-β pathways. In Vitro Cell Dev Biol Anim. 2016 Jan;52(1):120-9. doi: 10.1007/s11626-015-9954-3. Epub 2015 Oct 1. PubMed PMID: 26427712.

12: Jiang J, Zhang Y, Zhang Q, Li Y, Gong T, Zhang Z, Ding R, Sun X. Development and validation of an LC-MS/MS method for the determination of SB-505124 in rat plasma: Application to pharmacokinetic study. J Pharm Biomed Anal. 2016 Jan 5;117:205-9. doi: 10.1016/j.jpba.2015.09.002. Epub 2015 Sep 3. PubMed PMID: 26363490.

13: Li S, Niu G, Wu Y, Du G, Huang C, Yin X, Liu Z, Song C, Leng H. Vitamin D prevents articular cartilage erosion by regulating collagen II turnover through TGF-β1 in ovariectomized rats. Osteoarthritis Cartilage. 2016 Feb;24(2):345-53. doi: 10.1016/j.joca.2015.08.013. Epub 2015 Sep 4. PubMed PMID: 26343586.

14: Tekari A, Luginbuehl R, Hofstetter W, Egli RJ. Transforming growth factor beta signaling is essential for the autonomous formation of cartilage-like tissue by expanded chondrocytes. PLoS One. 2015 Mar 16;10(3):e0120857. doi: 10.1371/journal.pone.0120857. eCollection 2015. PubMed PMID: 25775021; PubMed Central PMCID: PMC4361600.

15: Brown KM, Suvorova E, Farrell A, McLain A, Dittmar A, Wiley GB, Marth G, Gaffney PM, Gubbels MJ, White M, Blader IJ. Forward genetic screening identifies a small molecule that blocks Toxoplasma gondii growth by inhibiting both host- and parasite-encoded kinases. PLoS Pathog. 2014 Jun 12;10(6):e1004180. doi: 10.1371/journal.ppat.1004180. eCollection 2014 Jun. PubMed PMID: 24945800; PubMed Central PMCID: PMC4055737.

16: Zhang S, Sun WY, Wu JJ, Wei W. TGF-β signaling pathway as a pharmacological target in liver diseases. Pharmacol Res. 2014 Jul;85:15-22. doi: 10.1016/j.phrs.2014.05.005. Epub 2014 May 17. Review. PubMed PMID: 24844437.

17: Uchinaka A, Kawaguchi N, Mori S, Hamada Y, Miyagawa S, Saito A, Sawa Y, Matsuura N. Tissue inhibitor of metalloproteinase-1 and -3 improves cardiac function in an ischemic cardiomyopathy model rat. Tissue Eng Part A. 2014 Nov;20(21-22):3073-84. doi: 10.1089/ten.TEA.2013.0763. Epub 2014 Jun 16. PubMed PMID: 24814095; PubMed Central PMCID: PMC4229714.

18: Choi SG, Wang Q, Jia J, Pincas H, Turgeon JL, Sealfon SC. Growth differentiation factor 9 (GDF9) forms an incoherent feed-forward loop modulating follicle-stimulating hormone β-subunit (FSHβ) gene expression. J Biol Chem. 2014 Jun 6;289(23):16164-75. doi: 10.1074/jbc.M113.537696. Epub 2014 Apr 28. PubMed PMID: 24778184; PubMed Central PMCID: PMC4047387.

19: Wu TH, Chou YW, Chiu PH, Tang MJ, Hu CW, Yeh ML. Validation of the effects of TGF-β1 on tumor recurrence and prognosis through tumor retrieval and cell mechanical properties. Cancer Cell Int. 2014 Mar 3;14(1):20. doi: 10.1186/1475-2867-14-20. PubMed PMID: 24581230; PubMed Central PMCID: PMC3973896.

20: Mikhailova A, Ilmarinen T, Uusitalo H, Skottman H. Small-molecule induction promotes corneal epithelial cell differentiation from human induced pluripotent stem cells. Stem Cell Reports. 2014 Feb 6;2(2):219-31. doi: 10.1016/j.stemcr.2013.12.014. eCollection 2014 Feb 11. PubMed PMID: 24527395; PubMed Central PMCID: PMC3923224.